Fanconi anemia is a hereditary cancer susceptibility disorder characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to DNA cross-linking agents such as mitomycin C. This phenotype suggests a possible role for the Fanconi anemia proteins in the repair of DNA lesions induced by these agents, but the molecular mechanism underlying the defect in this disorder has not yet been identified. Here, we show that amongst eight so far identified complementation groups of Fanconi anemia, only fibroblasts derived from group D1 are defective in the formation of nuclear Rad51 foci after X-ray irradiation or mitomycin C treatment. This indicates that the FANCD1 gene product is uniquely involved in the assembly and/or stabilization of the Rad51 complex. Since DNA damage-induced Rad51 nuclear foci are thought to reflect repair of DNA double-strand breaks by homologous recombination, our results suggest that FANCD1 is likely to be involved in homologous recombination-dependent repair.
Fanconi anemia (FA) is an autosomal recessive disorder with diverse clinical symptoms and a marked predisposition to malignancies. Moreover, cells from FA patients exhibit spontaneous chromosomal instability and hypersensitivity to DNA cross-linking agents such as mitomycin C (MMC) (Auerbach et al., 1998) . At least eight distinct FA genes have been implicated on the basis of complementation studies (Joenje and Patel, 2001) , six of which have been cloned (Lo Ten Foe et al, 1996 ; The Fanconi anemia/Breast cancer consortium 1996; Strathdee et al., 1992; Timmers et al., 2001; De Winter et al., 1998 , 2000a . Although their encoded proteins lack meaningful functional motifs, they are thought to act in an integrated DNA damage response pathway that is connected to BRCA1 (Garcia-Higuera et al., 2001) . In this pathway the proteins FANCA, -C, -E, -F, and -G form a nuclear multiprotein complex (De Winter et al., 2000c; Medhurst et al., 2001 ) that is essential for the activation of FANCD2 into a monoubiquitinated isoform, which colocalizes with BRCA1 in nuclear foci (Garcia-Higuera et al., 2001) . The genes for groups B and D1 have not yet been identified. Cells from group B are unable to form this multiprotein complex (De Winter et al., 2000c) , indicating that FANCB acts upstream in the FA pathway. Since activation of FANCD2 fails to take place in any of the complementation groups except D1 Garcia-Higuera et al., 2001) , FANCD1 has been proposed to act downstream in the FA pathway, or alternatively to function in a distinct pathway.
Given the hypersensitivity of all FA cells to agents causing DNA cross-links, which are supposed to be repaired by a process depending on homologous recombination (HR) (De Silva et al., 2000; Dronkert and Kanaar, 2001) , we determined the capacity of FA cells to form DNA damage-inducible nuclear foci that contain the central HR molecule, Rad51 (Haaf et al., 1995; Tashiro et al., 1996 Tashiro et al., , 2000 . Primary skin fibroblasts derived from patients belonging to the eight known FA complementation groups as assessed by somatic cell hybridization (Joenje and Patel, 2001) , were analysed for their ability to form nuclear Rad51 foci in response to DNA damage. This analysis revealed normal formation of nuclear Rad51 foci in cells from complementation groups A, B, C, D2, E, F and G after treatment with either MMC or X-rays, as in wild type cells (Table 1, Figure 1a) , furthermore, the dynamics of Rad51 foci formation in these cells was comparable to wild type cells (Figure 1b ). In untreated fibroblasts a level of about 5 -10% Rad51 foci-positive cells could be observed. Eight hours after treatment with X-rays or MMC the number of foci-positive cells increased to about 30 -40%. This level was maintained for up to at least 31 h after MMC treatment (results not shown) whereas after X-ray irradiation the number of Rad51 foci-positive cells declined after 24 h ( Figure  1b ). In contrast, fibroblasts derived from two unrelated FA-D1 patients (EUFA423, F145) showed a severely impaired formation of nuclear Rad51 foci (Figure 1 ). This strongly suggests that the FANCD1 gene product is required for the assembly and/or stabilization of the Rad51 protein complex and is thus likely to be involved in HR-dependent repair. The impaired Rad51 foci formation in FA-D1 cells could not be attributed to parameters like proliferative capacity since these fibroblasts had similar growth characteristics as FA-B, FA-E, and FA-F primary fibroblasts (results not shown) which were all Rad51 foci-positive (Table 1) . To show that FA-D1 fibroblasts were competent to form nuclear foci of different composition, the formation of Nbs1 and Mre11 foci was tested in FA-D1 fibroblasts and found to be normal, i.e. similar to FA-A and wild type fibroblasts (results not shown). Preliminary results also revealed the presence of BRCA1 foci in both FA-D1 fibroblast lines at levels comparable to wild type cells (results not shown).
Impaired Rad51 foci formation in response to DNA damage has also been reported in mammalian cells defective in Brca2 (Yuan et al., 1999; Kraakman-van der Zwet et al, 2002 ), Xrcc2 (O'Regan et al., 2001 , and Xrcc3 (Bishop et al., 1998) , as well as in chicken cells defective in Rad51 paralogs B, C and D (Takata et al., 2001) , all of which participate in HR and Rad51 focus formation. A similar defect in Rad51 foci formation brings these genes into focus as candidate genes for Moreover, we found no evidence for Xray-hypersensitivity of FA-D1 fibroblasts, based on clonogenic survival assays. Primary fibroblasts from complementation groups A (EUFA432), C (EUFA449) and D1 (EUFA423 and F145) all showed a normal response to X-ray irradiation in comparison to wild type fibroblasts, whereas ataxia telangiectasia (AT cells) were clearly sensitive (Figure 2 ). To determine whether the redistribution of the Rad51 protein in response to DNA damage is responsible for the severely impaired nuclear Rad51 foci formation in FA-D1 cells, we examined the subcellular localization of Rad51, before and after treatment with MMC. This analysis revealed the presence of Rad51 protein in the cytoplasmic as well as in the nuclear protein fractions in wild type (JVM), FA-A (HSC72) and in FA-D1 (HSC62) lymphoblasts before MMC treatment (Figure 3) . After the treatment an increase of Rad51 protein was observed in the cytoplasmic as well as in the nuclear protein fraction in wild type and FA-A lymphoblasts. Interestingly, in FA-D1 lymphoblasts only an increase of cytoplasmic Rad51 protein could be observed (Figure 3) , suggesting that the impaired Rad51 foci formation in FA-D1 cells might be due to lack of accumulation of Rad51 in the nucleus. These results suggest that the FANCD1 gene product is involved in the process of DNA damageinduced nuclear accumulation of Rad51. The impaired Rad51 foci formation and the putatively impaired accumulation of Rad51 in the nucleus in FA-D1 cells after DNA damage might connect FA with BRCA2, since BRCA2 has been found to regulate both the intracellular localization and the DNA binding ability of Rad51 (Davies et al., 2001) . The exact interaction between FANCD1, Rad51 and BRCA2 remains to be established and awaits cloning of the FANCD1 gene.
The observation that cell lines from complementation group D1 have an intact FANCA, -C, -E, -F and -G core complex and are able to monoubiquitinate FANCD2 (De Winter et al., 2000c; Garcia-Higuera et al, 2000) places them downstream of FANCD2 or alternatively in a separate pathway. The data presented here showing impaired nuclear Rad51 foci formation and lack of nuclear accumulation of Rad51 protein in FA-D1 cells in response to DNA damage point to a role of FANCD1 in a separate (sub) pathway. However, it may still be possible that all FA proteins interact in an integrated DNA damage response pathway in which the core complex is necessary for FANCD2 activation and FANCD1 functions downstream of FANCD2. The normal Rad51 foci formation that was observed in all other FA complementation groups might in that case be accounted for by a bypass mechanism, as was reported previously for cells with a defect in Nbs1 or ATM which are still able to form Rad51 foci (Maser et al., 1997; Dong et al., 1999) . A defect in ATM or Nbs1, both involved in the early steps of DNA double strand break (DSB) repair through HR apparently still gives rise to a downstream effector function, i.e. Rad51 foci formation. Moreover, previous studies have shown that repair of plasmid based, damaged substrates or DSBs that are introduced in endogenous loci occurs with reduced fidelity in FA-C and FA-D1 cells (Smith et al., 1998; Escarceller et al., 1998) , but the exact role of FA proteins in DNA cross-link repair is still unclear and remains to be established.
In summary, the FA-D1 complementation group displays a unique cellular phenotype implying a defective HR-based genome protection mechanism that may be distinct from that supported by the other FA proteins. Figure 3 Lack of accumulation of Rad51 in the nucleus in FA-D1 lymphoblasts after MMC treatment. Cytoplasmic (c) and nuclear (n) protein fractions were isolated, essentially according to Waisfisz et al. (1999) , prior to and 6 h after treatment of wild type (JVM), FA-A (HSC72) and FA-D1 (HSC62) lymphoblasts with MMC (2.4 mg/ml for 1 h), followed by immunoblot analysis of equal amounts of protein (25 mg) with rabbit anti-Rad51 (FBE1) antibodies (1 : 1000 dilution). Extracts were also immunoblotted with rabbit anti-topoisomerase I (Topo I; TopoGEN Inc.) antibodies as loading control and nuclear marker Figure 2 Lack of hypersensitivity to cell killing by X-ray irradiation in FA-D1 fibroblasts, measured by cloning efficiency. Primary fibroblasts of passage number 5 -15 were irradiated at the indicated doses and surviving clones were counted after 14 days of growth. Survival curves of wild type (FN1), FA-A (EUFA432), FA-C (EUFA449), FA-D1 (EUFA423, F145) and X-ray-sensitive AT (AT5BIVA) (Murnane et al., 1985) primary fibroblasts after different doses of X-ray irradiation are depicted. Data are the average of at least three independent experiments. Error bars represent the standard error of the mean (s.e.m.)
